ID   MAK_HUMAN               Reviewed;         623 AA.
AC   P20794; F1T0K6; G1FL29; Q547D0; Q9NUH7;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 2.
DT   15-MAR-2017, entry version 156.
DE   RecName: Full=Serine/threonine-protein kinase MAK;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:12084720, ECO:0000269|PubMed:21986944};
DE   AltName: Full=Male germ cell-associated kinase;
GN   Name=MAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, INDUCTION, AUTOPHOSPHORYLATION,
RP   PHOSPHORYLATION, AND MUTAGENESIS OF LYS-33.
RC   TISSUE=Testis;
RX   PubMed=12084720; DOI=10.1074/jbc.M203940200;
RA   Xia L., Robinson D., Ma A.H., Chen H.C., Wu F., Qiu Y., Kung H.J.;
RT   "Identification of human male germ cell-associated kinase, a kinase
RT   transcriptionally activated by androgen in prostate cancer cells.";
RL   J. Biol. Chem. 277:35422-35433(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), ALTERNATIVE SPLICING (ISOFORM
RP   2), VARIANTS RP62 SER-13; ARG-27; HIS-130; HIS-166 AND THR-181,
RP   CHARACTERIZATION OF VARIANTS RP62 SER-13 AND HIS-130, AND VARIANT
RP   LEU-325.
RC   TISSUE=Retina;
RX   PubMed=21835304; DOI=10.1016/j.ajhg.2011.07.005;
RA   Ozgul R.K., Siemiatkowska A.M., Yucel D., Myers C.A., Collin R.W.,
RA   Zonneveld M.N., Beryozkin A., Banin E., Hoyng C.B., van den Born L.I.,
RA   Bose R., Shen W., Sharon D., Cremers F.P., Klevering B.J.,
RA   den Hollander A.I., Corbo J.C.;
RT   "Exome sequencing and cis-regulatory mapping identify mutations in
RT   MAK, a gene encoding a regulator of ciliary length, as a cause of
RT   retinitis pigmentosa.";
RL   Am. J. Hum. Genet. 89:253-264(2011).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), ALTERNATIVE SPLICING (ISOFORM
RP   2), SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INVOLVEMENT IN RP62.
RC   TISSUE=Retina;
RX   PubMed=21825139; DOI=10.1073/pnas.1108918108;
RA   Tucker B.A., Scheetz T.E., Mullins R.F., DeLuca A.P., Hoffmann J.M.,
RA   Johnston R.M., Jacobson S.G., Sheffield V.C., Stone E.M.;
RT   "Exome sequencing and analysis of induced pluripotent stem cells
RT   identify the cilia-related gene male germ cell-associated kinase (MAK)
RT   as a cause of retinitis pigmentosa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:E569-E576(2011).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Retinoblastoma;
RX   PubMed=21697133; DOI=10.1167/iovs.11-7479;
RA   Oshikawa M., Tsutsui C., Ikegami T., Fuchida Y., Matsubara M.,
RA   Toyama S., Usami R., Ohtoko K., Kato S.;
RT   "Full-length transcriptome analysis of human retina-derived cell lines
RT   ARPE-19 and Y79 using the vector-capping method.";
RL   Invest. Ophthalmol. Vis. Sci. 52:6662-6670(2011).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 121-163.
RX   PubMed=2183027; DOI=10.1128/MCB.10.5.2261;
RA   Matsushime H., Jinno A., Takagi N., Shibuya M.;
RT   "A novel mammalian protein kinase gene (mak) is highly expressed in
RT   testicular germ cells at and after meiosis.";
RL   Mol. Cell. Biol. 10:2261-2268(1990).
RN   [8]
RP   FUNCTION, INTERACTION WITH AR, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=16951154; DOI=10.1158/0008-5472.CAN-06-1636;
RA   Ma A.H., Xia L., Desai S.J., Boucher D.L., Guan Y., Shih H.M.,
RA   Shi X.B., deVere White R.W., Chen H.W., Tepper C.G., Kung H.J.;
RT   "Male germ cell-associated kinase, a male-specific kinase regulated by
RT   androgen, is a coactivator of androgen receptor in prostate cancer
RT   cells.";
RL   Cancer Res. 66:8439-8447(2006).
RN   [9]
RP   FUNCTION, INTERACTION WITH CDK20 AND FZR1, CATALYTIC ACTIVITY,
RP   COFACTOR, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-157 AND
RP   TYR-159, AND MUTAGENESIS OF THR-157 AND TYR-159.
RX   PubMed=21986944; DOI=10.1038/onc.2011.464;
RA   Wang L.Y., Kung H.J.;
RT   "Male germ cell-associated kinase is overexpressed in prostate cancer
RT   cells and causes mitotic defects via deregulation of APC/C(CDH1).";
RL   Oncogene 31:2907-2918(2012).
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-189; PRO-272; SER-384; SER-520 AND
RP   LEU-550.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Essential for the regulation of ciliary length and
CC       required for the long-term survival of photoreceptors (By
CC       similarity). Phosphorylates FZR1 in a cell cycle-dependent manner.
CC       Plays a role in the transcriptional coactivation of AR. Could play
CC       an important function in spermatogenesis. May play a role in
CC       chromosomal stability in prostate cancer cells. {ECO:0000250,
CC       ECO:0000269|PubMed:12084720, ECO:0000269|PubMed:16951154,
CC       ECO:0000269|PubMed:21986944}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:12084720, ECO:0000269|PubMed:21986944}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:12084720,
CC         ECO:0000269|PubMed:21986944};
CC   -!- SUBUNIT: Interacts with RP1 (By similarity). Interacts with AR and
CC       CDK20. Found in a complex containing MAK, AR and NCOA3. Interacts
CC       with FZR1 (via WD repeats). {ECO:0000250,
CC       ECO:0000269|PubMed:16951154, ECO:0000269|PubMed:21986944}.
CC   -!- INTERACTION:
CC       P10275:AR; NbExp=5; IntAct=EBI-3911321, EBI-608057;
CC       Q9UM11:FZR1; NbExp=7; IntAct=EBI-3911321, EBI-724997;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome. Cytoplasm,
CC       cytoskeleton, spindle. Midbody. Cell projection, cilium,
CC       photoreceptor outer segment {ECO:0000250}. Photoreceptor inner
CC       segment. Note=Localized in both the connecting cilia and the outer
CC       segment axonemes (By similarity). Localized uniformly in nuclei
CC       during interphase, to the mitotic spindle and centrosomes during
CC       metaphase and anaphase, and also to midbody at anaphase until
CC       telophase. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P20794-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P20794-2; Sequence=VSP_042470;
CC       Name=3;
CC         IsoId=P20794-3; Sequence=VSP_042471;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in prostate cancer cell lines at
CC       generally higher levels than in normal prostate epithelial cell
CC       lines. Isoform 1 is expressed in kidney, testis, lung, trachea,
CC       and retina. Isoform 2 is retina-specific where it is expressed in
CC       rod and cone photoreceptors. {ECO:0000269|PubMed:12084720,
CC       ECO:0000269|PubMed:21825139}.
CC   -!- INDUCTION: Up-regulated by dihydrotestosterone (DHT) in androgen-
CC       sensitive LNCaP prostate cancer cells in a dose-dependent manner.
CC       Up-regulation by DHT is transient, reaching maximum levels after
CC       24 hours and decreases slightly after 48 hours.
CC       {ECO:0000269|PubMed:12084720}.
CC   -!- PTM: Autophosphorylated. Phosphorylated on serine and threonine
CC       residues. {ECO:0000269|PubMed:12084720,
CC       ECO:0000269|PubMed:21986944}.
CC   -!- DISEASE: Retinitis pigmentosa 62 (RP62) [MIM:614181]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies.
CC       Retinitis pigmentosa is characterized by retinal pigment deposits
CC       visible on fundus examination and primary loss of rod
CC       photoreceptor cells followed by secondary loss of cone
CC       photoreceptors. Patients typically have night vision blindness and
CC       loss of midperipheral visual field. As their condition progresses,
CC       they lose their far peripheral visual field and eventually central
CC       vision as well. {ECO:0000269|PubMed:21825139,
CC       ECO:0000269|PubMed:21835304}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF505623; AAN16405.1; -; mRNA.
DR   EMBL; JN226411; AEL29206.1; -; mRNA.
DR   EMBL; AB593146; BAJ84080.1; -; mRNA.
DR   EMBL; AL024498; CAB75823.1; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55283.1; -; Genomic_DNA.
DR   EMBL; M35863; AAA36195.1; -; Genomic_DNA.
DR   CCDS; CCDS4516.1; -. [P20794-1]
DR   CCDS; CCDS75398.1; -. [P20794-3]
DR   CCDS; CCDS75399.1; -. [P20794-2]
DR   PIR; B34711; B34711.
DR   RefSeq; NP_001229314.1; NM_001242385.1. [P20794-3]
DR   RefSeq; NP_001229886.1; NM_001242957.2. [P20794-2]
DR   RefSeq; NP_005897.1; NM_005906.5. [P20794-1]
DR   RefSeq; XP_011512921.1; XM_011514619.2. [P20794-2]
DR   RefSeq; XP_011512922.1; XM_011514620.2. [P20794-2]
DR   RefSeq; XP_011512924.1; XM_011514622.2. [P20794-3]
DR   RefSeq; XP_016866352.1; XM_017010863.1. [P20794-2]
DR   RefSeq; XP_016866353.1; XM_017010864.1. [P20794-1]
DR   UniGene; Hs.446125; -.
DR   ProteinModelPortal; P20794; -.
DR   SMR; P20794; -.
DR   BioGrid; 110291; 11.
DR   IntAct; P20794; 12.
DR   STRING; 9606.ENSP00000313021; -.
DR   BindingDB; P20794; -.
DR   ChEMBL; CHEMBL1163106; -.
DR   GuidetoPHARMACOLOGY; 2061; -.
DR   iPTMnet; P20794; -.
DR   PhosphoSitePlus; P20794; -.
DR   BioMuta; MAK; -.
DR   DMDM; 13432166; -.
DR   PaxDb; P20794; -.
DR   PeptideAtlas; P20794; -.
DR   PRIDE; P20794; -.
DR   DNASU; 4117; -.
DR   Ensembl; ENST00000313243; ENSP00000313021; ENSG00000111837. [P20794-1]
DR   Ensembl; ENST00000354489; ENSP00000346484; ENSG00000111837. [P20794-2]
DR   Ensembl; ENST00000474039; ENSP00000476067; ENSG00000111837. [P20794-1]
DR   Ensembl; ENST00000536370; ENSP00000442221; ENSG00000111837. [P20794-3]
DR   GeneID; 4117; -.
DR   KEGG; hsa:4117; -.
DR   UCSC; uc003mzm.4; human. [P20794-1]
DR   CTD; 4117; -.
DR   DisGeNET; 4117; -.
DR   GeneCards; MAK; -.
DR   GeneReviews; MAK; -.
DR   HGNC; HGNC:6816; MAK.
DR   HPA; HPA039092; -.
DR   MalaCards; MAK; -.
DR   MIM; 154235; gene.
DR   MIM; 614181; phenotype.
DR   neXtProt; NX_P20794; -.
DR   OpenTargets; ENSG00000111837; -.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA30564; -.
DR   eggNOG; KOG0661; Eukaryota.
DR   eggNOG; ENOG410XPBB; LUCA.
DR   GeneTree; ENSGT00650000093283; -.
DR   HOGENOM; HOG000233024; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P20794; -.
DR   KO; K08829; -.
DR   OMA; YATYNQS; -.
DR   OrthoDB; EOG091G0DU3; -.
DR   PhylomeDB; P20794; -.
DR   TreeFam; TF328769; -.
DR   BRENDA; 2.7.11.22; 2681.
DR   SignaLink; P20794; -.
DR   GeneWiki; MAK_(gene); -.
DR   GenomeRNAi; 4117; -.
DR   PRO; PR:P20794; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000111837; -.
DR   CleanEx; HS_MAK; -.
DR   ExpressionAtlas; P20794; baseline and differential.
DR   Genevisible; P20794; HS.
DR   GO; GO:0005930; C:axoneme; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0097542; C:ciliary tip; IEA:Ensembl.
DR   GO; GO:0005929; C:cilium; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0031514; C:motile cilium; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032391; C:photoreceptor connecting cilium; IEA:Ensembl.
DR   GO; GO:0001917; C:photoreceptor inner segment; IDA:UniProtKB.
DR   GO; GO:0001750; C:photoreceptor outer segment; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; NAS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0060271; P:cilium assembly; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0042073; P:intraciliary transport; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:1902856; P:negative regulation of non-motile cilium assembly; IEA:Ensembl.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007283; P:spermatogenesis; NAS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell projection; Cilium;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Developmental protein;
KW   Differentiation; Disease mutation; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Retinitis pigmentosa;
KW   Serine/threonine-protein kinase; Spermatogenesis; Transcription;
KW   Transcription regulation; Transferase.
FT   CHAIN         1    623       Serine/threonine-protein kinase MAK.
FT                                /FTId=PRO_0000086284.
FT   DOMAIN        4    284       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      10     18       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS    309    368       Glu/Pro-rich.
FT   ACT_SITE    125    125       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      33     33       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     157    157       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:21986944}.
FT   MOD_RES     159    159       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:21986944}.
FT   VAR_SEQ     532    532       A -> AEESIIKPIEKLSCNETFPEKLEDPQ (in
FT                                isoform 2). {ECO:0000303|PubMed:21825139,
FT                                ECO:0000303|PubMed:21835304}.
FT                                /FTId=VSP_042470.
FT   VAR_SEQ     533    572       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:21697133}.
FT                                /FTId=VSP_042471.
FT   VARIANT      13     13       G -> S (in RP62; results in a complete
FT                                loss of kinase activity compared to wild-
FT                                type; dbSNP:rs387906647).
FT                                {ECO:0000269|PubMed:21835304}.
FT                                /FTId=VAR_066988.
FT   VARIANT      27     27       G -> R (in RP62; dbSNP:rs754916169).
FT                                {ECO:0000269|PubMed:21835304}.
FT                                /FTId=VAR_066989.
FT   VARIANT     130    130       N -> H (in RP62; results in a complete
FT                                loss of kinase activity compared to wild-
FT                                type; dbSNP:rs387906646).
FT                                {ECO:0000269|PubMed:21835304}.
FT                                /FTId=VAR_066990.
FT   VARIANT     166    166       R -> H (in RP62; dbSNP:rs387906648).
FT                                {ECO:0000269|PubMed:21835304}.
FT                                /FTId=VAR_066991.
FT   VARIANT     181    181       I -> T (in RP62; dbSNP:rs750559316).
FT                                {ECO:0000269|PubMed:21835304}.
FT                                /FTId=VAR_066992.
FT   VARIANT     189    189       I -> V (in dbSNP:rs56215624).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042006.
FT   VARIANT     272    272       R -> P (in a breast infiltrating ductal
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042007.
FT   VARIANT     325    325       P -> L (in dbSNP:rs371971492).
FT                                {ECO:0000269|PubMed:21835304}.
FT                                /FTId=VAR_066993.
FT   VARIANT     329    329       D -> E (in dbSNP:rs17579447).
FT                                /FTId=VAR_053932.
FT   VARIANT     384    384       N -> S (in dbSNP:rs55773478).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042008.
FT   VARIANT     520    520       P -> S (in dbSNP:rs567083).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042009.
FT   VARIANT     550    550       F -> L (in dbSNP:rs56217305).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042010.
FT   MUTAGEN      33     33       K->R: Abolishes autophosphorylation.
FT                                {ECO:0000269|PubMed:12084720}.
FT   MUTAGEN     157    157       T->A: Abolishes autophosphorylation and
FT                                impairs kinase activity.
FT                                {ECO:0000269|PubMed:21986944}.
FT   MUTAGEN     159    159       Y->F: Abolishes autophosphorylation and
FT                                impairs kinase activity.
FT                                {ECO:0000269|PubMed:21986944}.
SQ   SEQUENCE   623 AA;  70581 MW;  67F540266F370285 CRC64;
     MNRYTTMRQL GDGTYGSVLM GKSNESGELV AIKRMKRKFY SWDECMNLRE VKSLKKLNHA
     NVIKLKEVIR ENDHLYFIFE YMKENLYQLM KDRNKLFPES VIRNIMYQIL QGLAFIHKHG
     FFHRDMKPEN LLCMGPELVK IADFGLAREL RSQPPYTDYV STRWYRAPEV LLRSSVYSSP
     IDVWAVGSIM AELYMLRPLF PGTSEVDEIF KICQVLGTPK KSDWPEGYQL ASSMNFRFPQ
     CVPINLKTLI PNASNEAIQL MTEMLNWDPK KRPTASQALK HPYFQVGQVL GPSSNHLESK
     QSLNKQLQPL ESKPSLVEVE PKPLPDIIDQ VVGQPQPKTS QQPLQPIQPP QNLSVQQPPK
     QQSQEKPPQT LFPSIVKNMP TKPNGTLSHK SGRRRWGQTI FKSGDSWEEL EDYDFGASHS
     KKPSMGVFKE KRKKDSPFRL PEPVPSGSNH STGENKSLPA VTSLKSDSEL STAPTSKQYY
     LKQSRYLPGV NPKKVSLIAS GKEINPHTWS NQLFPKSLGP VGAELAFKRS NAGNLGSYAT
     YNQSGYIPSF LKKEVQSAGQ RIHLAPLNAT ASEYTWNTKT GRGQFSGRTY NPTAKNLNIV
     NRAQPIPSVH GRTDWVAKYG GHR
//
